Evidence map›Paper›PMID 28029547›Full record

ArticleColloids and surfaces. B, Biointerfaces2017

Improving sensitivity and specificity of capturing and detecting targeted cancer cells with anti-biofouling polymer coated magnetic iron oxide nanoparticles.

Run Lin, Yuancheng Li, Tobey MacDonald, Hui Wu, James Provenzale, Xingui Peng, Jing Huang, Liya Wang, Andrew Y Wang, Jianyong Yang and 1 more

Abstract read
In one paragraph

Article in Colloids and surfaces. B, Biointerfaces, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Biology · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Impact of nanoparticles on neuron biology: current research trends.International journal of nanomedicine · 2018
    Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Run LinDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
Yuancheng LiDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
Tobey MacDonaldDepartment of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Hui WuDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
James ProvenzaleDepartment of Radiology, Duke University Medical Center, Durham, NC 27710, USA.
Xingui PengDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Radiology, The Medical College of Southeastern University, Nanjing, Jiangsu, China.
Jing HuangDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
Liya WangDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA.
Andrew Y WangOcean NanoTech, LLC, San Diego, CA 20046, USA.
Jianyong YangDepartment of Radiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
Hui MaoDepartment of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: hmao@emory.edu.

Funding

Targeted therapy of peritoneal carcinomatosis using theranostic nanoparticlesR01CA202846 · NCI · EMORY UNIVERSITY · PI MAO, HUI, WANG, YONGQIANG ANDREW · 2016 to 2020
$2.4M
Theranostic Nano particles for Targeted Treatment of Pancreatic CancerU01CA151810 · NCI · EMORY UNIVERSITY · PI MAO, HUI, YANG, LILY · 2010 to 2014
$2.2M
MRI Capable Receptor Targeted Drug Delivery for Pancreatic CancerR01CA154846 · NCI · EMORY UNIVERSITY · PI MAO, HUI, YANG, LILY · 2011 to 2015
$2.1M
NCI NIH HHS R01 CA154846NCI NIH HHS R01 CA202846NCI NIH HHS U01 CA151810
6 · The paper itself

Abstract

Detecting circulating tumor cells (CTCs) with high sensitivity and specificity is critical to management of metastatic cancers. Although immuno-magnetic technology for in vitro detection of CTCs has shown promising potential for clinical applications, the biofouling effect, i.e., non-specific adhesion of biomolecules and non-cancerous cells in complex biological samples to the surface of a device/probe, can reduce the sensitivity and specificity of cell detection. Reported herein is the application of anti-biofouling polyethylene glycol-block-allyl glycidyl ether copolymer (PEG-b-AGE) coated iron oxide nanoparticles (IONPs) to improve the separation of targeted tumor cells from aqueous phase in an external magnetic field. PEG-b-AGE coated IONPs conjugated with transferrin (Tf) exhibited significant anti-biofouling properties against non-specific protein adsorption and off-target cell uptake, thus substantially enhancing the ability to target and separate transferrin receptor (TfR) over-expressed D556 medulloblastoma cells. Tf conjugated PEG-b-AGE coated IONPs exhibited a high capture rate of targeted tumor cells (D556 medulloblastoma cell) in cell media (58.7±6.4%) when separating 100 targeted tumor cells from 1×10

Indexed as

BiofoulingAdsorptionAnimalsBiomarkersCell Line, TumorCell ProliferationCell SurvivalFerric CompoundsHumansLigandsLightMacrophagesMagneticsMagnetite NanoparticlesMiceMicroscopy, FluorescenceBiomarkersFerric Compoundsferric oxideLigandsMagnetite NanoparticlesPolyethylene GlycolsPolymersReceptors, TransferrinTransferrinAnti-biofoulingCell separationCirculating tumor cellsMagnetic nanoparticlesTargeting

Identifiers

PMID28029547
PMCPMC5253252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.